ENDOR AG/ DE0005491666 /
5/17/2024 9:59:02 PM | Chg. -0.001 | Volume | Bid9:59:02 PM | Ask9:59:02 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.199EUR | -0.50% | 48,422 Turnover: 10,386.290 |
-Bid Size: - | -Ask Size: - | 3.08 mill.EUR | - | 1.00 |
GlobeNewswire
3/28
CIO Leadership: Celebrating Charlie Feld and Other Recipients of HMG Strategy’s Global Leadership In...
GlobeNewswire
5/1/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
4/28/2020
Rigrodsky & Long, P.A. Files Class Action Suit Against Neon Therapeutics, Inc.
GlobeNewswire
4/24/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, SBBX, QUMU, and MSBF Shareholders About Its Ongoing In...
GlobeNewswire
4/17/2020
SHAREHOLDER ALERT: WeissLaw LLP Reminds NTGN, MSBF, QUMU and SBBX Shareholders About Its Ongoing Inv...
GlobeNewswire
3/2/2020
Neon Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results and Provides Business ...
GlobeNewswire
1/16/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies
GlobeNewswire
1/16/2020
BioNTech to acquire Neon to strengthen global leadership position in T cell therapies